Alnylam Pharmaceuticals shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $46M | 102k | 455.93 |
| 2025-06-30 | $41M | 126k | 326.07 |
| 2025-03-31 | $45M | 167k | 270.01 |
| 2024-12-31 | $57M | 240k | 235.31 |
| 2024-09-30 | $62M | 224k | 275.03 |
| 2024-06-30 | $21M | 87k | 243.00 |
| 2024-03-31 | $13M | 87k | 149.45 |
| 2023-12-31 | $17M | 87k | 191.41 |
| 2018-09-30 | $5.4M | 62k | 87.52 |
| 2018-06-30 | $6.1M | 62k | 98.48 |
| 2018-03-31 | $7.4M | 62k | 119.10 |
| 2017-12-31 | $11M | 90k | 127.06 |
| 2017-09-30 | $11M | 90k | 117.49 |
| 2017-06-30 | $7.2M | 90k | 79.76 |
| 2017-03-31 | $4.6M | 90k | 51.26 |
| 2016-12-31 | $3.4M | 90k | 37.44 |
| 2016-09-30 | $6.1M | 90k | 67.78 |
| 2016-06-30 | $5.0M | 90k | 55.49 |
| 2016-03-31 | $5.6M | 90k | 62.77 |
| 2015-12-31 | $8.5M | 90k | 94.14 |
| 2015-09-30 | $5.7M | 71k | 80.35 |
| 2015-06-30 | $5.5M | 46k | 119.87 |
| 2015-03-31 | $4.4M | 42k | 104.42 |